Avidity Biosciences
RNA
#1825
Rank
NZ$18.57 B
Marketcap
NZ$123.30
Share price
0.06%
Change (1 day)
96.04%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: NZ$18.57 Billion

As of December 2025 Avidity Biosciences has a market cap of NZ$18.57 Billion. This makes Avidity Biosciences the world's 1825th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$18.57 B191.66%
2024NZ$6.36 B462.18%
2023NZ$1.13 B-51.22%
2022NZ$2.32 B42.33%
2021NZ$1.63 B22.96%
2020NZ$1.32 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Avidity Biosciences was reported to be:

NZ$18.57 Billion
by Nasdaq info icon info icon
NZ$18.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
NZ$10.20 B-45.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.41 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$4.01 B-78.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.79 B-74.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.20 B-98.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.90 B 1.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$249.05 B 1,240.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$165.11 B 788.77%๐Ÿ‡ฌ๐Ÿ‡ง UK